SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-009164
Filing Date
2023-03-20
Accepted
2023-03-20 20:09:07
Documents
2
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1553
2 EX-24 DOCUMENT attachment1.htm EX-24 3991
  Complete submission text file 0000899243-23-009164.txt   6895
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMYLYX PHARMACEUTICALS, INC. 43 THORNDIKE ST. CAMBRIDGE MA 02141
Business Address
Firestone Karen (Reporting) CIK: 0001969821 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41199 | Film No.: 23747609